Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study

BACKGROUND: Metastatic breast cancer (MBC) is a challenging disease, and despite new therapies, prognosis is still poor for a majority of patients. There is a clinical need for improved prognostication where immuno-oncology markers can provide important information. The aim of this study was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnarsdottir, Frida Björk, Bendahl, Pär-Ola, Johansson, Alexandra, Benfeitas, Rui, Rydén, Lisa, Bergenfelz, Caroline, Larsson, Anna-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031935/
https://www.ncbi.nlm.nih.gov/pubmed/36945037
http://dx.doi.org/10.1186/s13058-023-01631-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031935/
https://www.ncbi.nlm.nih.gov/pubmed/36945037
http://dx.doi.org/10.1186/s13058-023-01631-6

Ejemplares similares